UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects

Alimentary pharmacology & therapeutics, 2008-01, Vol.27 (2), p.186-196

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro‐oesophageal reflux disease groups

Alimentary pharmacology & therapeutics, 2007-07, Vol.26 (1), p.41-48

2007

Link zum Volltext

Verfügbarkeit prüfen

Consequences of frequent nocturnal gastro‐oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity

Alimentary pharmacology & therapeutics, 2007-02, Vol.25 (4), p.487-500

2007

Link zum Volltext

Verfügbarkeit prüfen

Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain

Alimentary pharmacology & therapeutics, 2007-07, Vol.26 (2), p.237-248

2007

Link zum Volltext

Verfügbarkeit prüfen

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population‐based study

Alimentary pharmacology & therapeutics, 2015-05, Vol.41 (9), p.856-866

2015

Link zum Volltext

Verfügbarkeit prüfen

Dyspepsia and irritable bowel syndrome in China: a population‐based endoscopy study of prevalence and impact

Alimentary pharmacology & therapeutics, 2010-08, Vol.32 (4), p.562-572

2010

Link zum Volltext

Verfügbarkeit prüfen

Editorial: you bet your life – medication risk taking by gastroparesis patients in a hypothetical exercise

Alimentary pharmacology & therapeutics, 2019-04, Vol.49 (8), p.1096-1097

Hasler, William L.

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi‐center, placebo‐controlled trial

Alimentary pharmacology & therapeutics, 2007-07, Vol.26 (1), p.107-116

2007

Link zum Volltext

Verfügbarkeit prüfen

Elevated serum interleukin‐2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease

Alimentary pharmacology & therapeutics, 2019-10, Vol.50 (8), p.901-910

2019

Link zum Volltext

Verfügbarkeit prüfen

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity

Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (8), p.1000-1010

2015

Link zum Volltext

Verfügbarkeit prüfen

Evidence that independent gut‐to‐brain and brain‐to‐gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1‐year population‐based prospective study

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (6), p.592-600

2016

Link zum Volltext

Verfügbarkeit prüfen

The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy

Alimentary pharmacology & therapeutics, 2015-11, Vol.42 (9), p.1093-1100

2015

Link zum Volltext

Verfügbarkeit prüfen

The impact of pre‐endoscopy proton pump inhibitor use on the classification of non‐erosive reflux disease and erosive oesophagitis

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (10), p.1266-1274

2010

Link zum Volltext

Verfügbarkeit prüfen

In‐patient discharge rates for the irritable bowel syndrome – an analysis of national trends in the United States from 1997 to 2010

Alimentary pharmacology & therapeutics, 2013-12, Vol.38 (11-12), p.1338-1346

2013

Link zum Volltext

Verfügbarkeit prüfen

Prokinetic effect of gut‐oriented hypnosis on gastric emptying

Alimentary pharmacology & therapeutics, 2006-04, Vol.23 (8), p.1241-1249

2006

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease

Alimentary pharmacology & therapeutics, 2021-08, Vol.54 (4), p.402-411

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation

Alimentary pharmacology & therapeutics, 2020-08, Vol.52 (3), p.430-441

2020

Link zum Volltext

Verfügbarkeit prüfen

Reflux symptoms are associated with psychiatric disease

Alimentary pharmacology & therapeutics, 2001-12, Vol.15 (12), p.1907-1912

2001

Link zum Volltext

Verfügbarkeit prüfen

Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M)

Alimentary pharmacology & therapeutics, 2021-12, Vol.54 (S1), p.S63-S74

2021

Link zum Volltext

Verfügbarkeit prüfen

Review article: management of oesophageal adenocarcinoma — control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus

Alimentary pharmacology & therapeutics, 2004-10, Vol.20 (s5), p.71-80

2004

Link zum Volltext

Verfügbarkeit prüfen

Review article: the treatment of acute biliary pancreatitis

Alimentary pharmacology & therapeutics, 1999-11, Vol.13 (11), p.1379-1389

1999

Link zum Volltext

Verfügbarkeit prüfen

Review article: the treatment of functional abdominal bloating and distension

Alimentary pharmacology & therapeutics, 2011-05, Vol.33 (10), p.1071-1086

2011

Link zum Volltext

Verfügbarkeit prüfen

Review: What do we mean by GERD? – definition and diagnosis

Alimentary pharmacology & therapeutics, 2005-08, Vol.22 (s1), p.2-10

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (5), p.587-599

2012

Link zum Volltext

Verfügbarkeit prüfen

Severe symptoms of gastro‐oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population‐based study

Alimentary pharmacology & therapeutics, 2008-01, Vol.27 (1), p.58-65

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

SpracheFranzösisch

Nur zeigenMit Volltextzugriff

Zeitschrift / SerieAlimentary Pharmacology & Therapeutics

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Gastroenterology & Hepatology
(35)
Life Sciences & Biomedicine
(35)
Pharmacology & Pharmacy
(35)
Science & Technology
(35)
Female
(26)
Male
(26)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Middle Aged
(24)
Gastroenterology. Liver. Pancreas. Abdomen
(23)
Adult
(22)
Digestive System
(22)
Pharmacology. Drug Treatments
(21)
Aged
(17)
Other Diseases. Semiology
(17)
Surveys And Questionnaires
(10)
Aged, 80 And Over
(8)
Esophagus
(8)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(8)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Alimentary Pharmacology And Therapeutics. Supplement
(2)

Menü

Weitere Dienste

Einstellungen

Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects

Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro‐oesophageal reflux disease groups

Consequences of frequent nocturnal gastro‐oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity

Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population‐based study

Dyspepsia and irritable bowel syndrome in China: a population‐based endoscopy study of prevalence and impact

Editorial: you bet your life – medication risk taking by gastroparesis patients in a hypothetical exercise

Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi‐center, placebo‐controlled trial

Elevated serum interleukin‐2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity

Evidence that independent gut‐to‐brain and brain‐to‐gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1‐year population‐based prospective study

The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy

The impact of pre‐endoscopy proton pump inhibitor use on the classification of non‐erosive reflux disease and erosive oesophagitis

In‐patient discharge rates for the irritable bowel syndrome – an analysis of national trends in the United States from 1997 to 2010

Prokinetic effect of gut‐oriented hypnosis on gastric emptying

Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease

Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation

Reflux symptoms are associated with psychiatric disease

Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M)

Review article: management of oesophageal adenocarcinoma — control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus

Review article: the treatment of acute biliary pancreatitis

Review article: the treatment of functional abdominal bloating and distension

Review: What do we mean by GERD? – definition and diagnosis

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation

Severe symptoms of gastro‐oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population‐based study

Aktive Filter

Suchergebnisse filtern